22UA Dividend History & Analysis | N/A Yield
22UA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Dividends Cash Amount per Share Yearly
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 20.9% | 0.31% |
| GILD | 155,333 M | 3.14% | 7.99% |
| ABBV | 410,546 M | 2.86% | 7.80% |
| AMGN | 180,930 M | 2.83% | 4.98% |
| HLN | 44,016 M | 1.83% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 7,645 M | 127% | 60.7% |
| HLN | 44,016 M | 51.0% | 100% |
| AMGN | 180,930 M | 8.90% | 100% |
| ABBV | 410,546 M | 7.06% | 100% |
| GILD | 155,333 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare 22UA Dividends with its Peer-Group
2.86% Yield
2.83% Yield
3.14% Yield
1.83% Yield
22UA Dividend History: Last 1 Payments (EUR) as of November 2025
| Ex-Dividend Date | Record Date | Payment Date | Period | Dividend per Share | Dividend Growth Rate QoQ | Payout Yield |
|---|---|---|---|---|---|---|
| 2022-06-02 | 1.8341 | 0% | 1.21% |
22UA Dividend FAQ
BioNTech SE (XETRA: 22UA) is a German biotechnology firm focused on developing and commercializing mRNA-based immunotherapies for cancer and infectious diseases. Founded in 2008 and headquartered in Mainz, the company leverages its proprietary mRNA platform to generate a broad pipeline of therapeutic candidates.
What is the Dividend Yield of 22UA?
As of November 2025, 22UA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - EUR by the current share price of 87.15.Does 22UA pay a dividend?
As of November 2025 22UA does not pay a dividend.How often does 22UA pay dividends?
Over the last 12 months, 22UA has issued 0 dividend payments. The last dividend payment was made on 2022-06-02.Will 22UA pay dividends in 2025?
The latest dividend paid per share was 1.83412 EUR with an Ex-Dividend Date of 2022-06-02. The next Ex-Dividend date for BioNTech SE (22UA) is currently unknown.What is the next Ex-Dividend Date for 22UA?
The next Ex-Dividend date for BioNTech SE (22UA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of 22UA?
22UA's average dividend growth rate over the past 5 years is -100.00% per year.
Negative growth: 22UA's Dividend growth is negative and declining.
What is the Yield on Cost of 22UA?
22UA's 5-Year Yield on Cost is -%. If you bought 22UA's shares at 89.17 EUR five years ago, your current annual dividend income (- EUR per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of 22UA?
22UA Payout Consistency is 1.7%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: BioNTech SE has a poor track record of dividend payments over its lifetime.
Does 22UA have a good Dividend Yield?
22UA`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of 22UA?
The Dividend Payout Ratio of 22UA is unknown.What is the Dividend Rating of 22UA?
22UA`s Overall Dividend Rating is 1.00%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.